Eli Lilly and Company

Indiana
Pharmaceuticals Biotechnology and Life Sciences

Corprate Bias Ratings

Risk Level:

Rating - Caution
Medium Risk

Eli Lilly and Company vets vendors according to LGBTQ policies and does not provide its employees with protections against viewpoint discrimination. However, it has not publicly terminated business relationships based on views or beliefs. The company covers the cost of "medically necessary transition-related care" for its employees and their children. The company pledged $25 million to BLM and related causes and denounced religious freedom legislation. Eli Lilly has also spoken out against state efforts to reform its own election processes. The company has funded Planned Parenthood and multiple LGBT organizations. However, it has not used its PAC contributions for ideological purposes. For these reasons, Eli Lilly receives a Medium Risk rating.

Criteria
Risk Level
Rationale
Corporate Weaponization
Criteria

Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level
Rationale

Eli Lilly and Company has not publicly terminated business relationships due to religious beliefs or political views. The company received a score of 100 on the Corporate Equality Index. Among other requirements, this means Eli Lilly has pledged to vet vendors based on LGBTQ policies (1)(2).

Criteria

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level
Rationale

The Lilly Foundation matches employee donations to health, education, and culture organizations. Contributions made “primarily for religious purposes” or to organizations that “promote religion” are ineligible (1).

Criteria

Employment policies fail to protect against discrimination based on political affiliation/views and/or religion.

Risk Level
Rationale

Eli Lilly does not have viewpoint protection for its employees in its nondiscrimination policy (1).

Corporate Governance and Public Policy
Criteria

Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.

Risk Level
Rationale

Eli Lilly advocates for the Equality Act (1). Eli Lilly put out a commercial featuring a seemingly transgender man and uses the language, “the body you are randomly assigned at birth shouldn’t determine how well you are cared for” (2). The company also spoke out against Indiana’s state legislature revising election procedures after the pandemic and against the state’s religious freedom restoration act law in 2015 (3). The company criticized the state’s abortion ban, saying “that it would be forced to look outside the state for employment growth” (4).

Criteria

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level
Rationale

Eli Lilly has a perfect score on the HRC’s 2022 Corporate Equality Index. This score indicates the company covers the cost of “medically necessary transition-related care” for its employees and their children (1)(2). Eli Lilly has previously funded Planned Parenthood (3). It is unclear if the company is currently supporting the organization. Eli Lilly has pledged $25 million to the Black Lives Matter movement and related causes (4)(5). Eli Lilly is a copper sponsor of Out & Equal and a corporate partner of the National LGBT Chamber of Commerce (6)(7).

Criteria

Uses corporate political contributions for ideological, non-business purposes.

Risk Level
Rationale

Eli Lilly has not used its PAC donations for ideological purposes (1)(2).

All links were last accessed and all information was updated on:
August 28, 2023

Company reports are intended for educational use only. Full Disclaimer

Voting History

Date
ESG Category
Proponent
Summary of ResolutionMgmt RecTotal Vote % in Favor
5/1/23SocialNational Center for Public PolicyReport on Risks of Supporting AbortionAgainst1.90%
5/1/23GovernanceSEIU Master TrustReport Disclosing Lobbying ActivityAgainst31.40%
5/1/23SocialTrinity HealthReport on Impact of Patent Process on Product AccessAgainst10.40%
5/1/23SocialAs You SowReport on the Effectiveness of the Company's Diversity, Equity, and Inclusion EffortsAgainst27.10%
5/1/23SocialAs You Sow, on behalf of Leslie Oelsner Bene IRA of S Berman (S), Sarah B Sonnenfeld Rev Tr (S), Curtis Overway and Marcelina Cravat-OverwayGreater Disclosure of Material Corporate DiversityAgainst27.10%
5/1/23GovernanceJohn CheveddenEliminate Supermajority Voting RequirementsAgainst40.70%
5/1/23GovernanceCommonSpirit HealthReport on Lobbying Values CongruencyAgainst22.50%
5/1/23GovernanceChange FinanceRequire Indirect Political Spending ReportingAgainst4.10%
5/2/22GovernanceLegal & General Invest. Mgmt. America, Inc.Independent Board ChairAgainst34.54%
5/2/22SocialCommonSpirit HealthDisclose Lobbying Activities & Alignment with Public Policy PositionsAgainst34.00%
5/2/22GovernanceTrinity HealthReport Oversight of Risks Related to Anticompetitive Pricing StrategiesAgainst22.78%
5/2/22SocialSEIU Master TrustReport on Lobbying Payments and PolicyAgainst37.03%
Generate Reports
Clear
Toast